bioAffinity Technologies BIAF Cash Flow Statement (2021-2026)

NASDAQ BIAF
$2.20 -0.14 (-5.98%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

bioAffinity Technologies Quarterly Cash Flow Statement

Periods 21 quarters
Latest Sep 2026

bioAffinity Technologies reported cash from operations of -$0.00B and free cash flow of -$0.00B for the quarter ended Sep 2026, down 56.1% year over year. This cash flow statement covers 21 quarters of results from Sep 2021 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-5.58M-1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M-3.14M-3.63M-3.37M-5.28M
Depreciation and DepletionDep. & Depletion
0.00M0.00M800.000.01M0.02M0.02M0.05M0.17M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.02M0.02M0.03M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
794.000.00M0.00M773.000.01M0.02M0.02M0.06M0.15M0.15M0.15M0.15M0.15M0.15M0.11M0.11M0.12M0.11M0.06M0.07M
Share-based CompensationStock Comp.
-89.52M0.11M0.03M0.08M0.04M0.16M0.17M0.09M0.23M0.28M0.29M0.19M0.23M0.33M0.22M0.07M0.07M0.01M0.78M0.14M
Gains from Sales and DivestituresGains Divest
-2.75M-1.22M
Gains from Investment SecuritiesGains Investment
2.75M
Other non-cash itemsOther Non-Cash
4.56M0.98M-0.21M0.77M0.08M2.75M-0.53M
Change in Working Capital
Change in ReceivablesChange Receivables
0.01M956.000.00M559.00538.000.08M-0.15M-0.24M0.31M0.47M-0.27M-0.19M-0.18M-0.54M0.03M0.09M0.14M0.21M-0.15M
Change in InventoryChange Inventory
0.01M-146.0058.00-175.000.01M0.00M-193.000.01M-0.01M0.02M0.00M0.00M0.01M0.01M-0.01M0.02M0.02M0.00M0.03M
Change in Account PayablesChange Payables
-0.03M0.02M0.34M-0.44M0.20M-0.20M0.03M0.58M-0.42M-0.22M0.46M-0.07M0.20M0.39M-0.21M-0.23M-0.18M0.07M0.13M-0.02M
Change in Accrued ExpensesChange Accrued Exp.
0.16M0.17M0.17M0.13M-0.03M-0.06M0.03M-0.12M0.51M-0.27M0.09M-0.06M0.49M-0.03M-0.32M-0.06M0.73M0.31M-0.61M-0.27M
Change in Other Operating AssetsOther Assets Change
-0.02M-0.01M-0.02M0.53M-0.01M-0.09M-0.16M0.09M-0.06M0.02M-0.09M0.19M-0.02M-0.01M-0.02M0.06M0.06M-0.07M-0.01M-0.03M
Change in Other Operating LiabilitiesOther Liabilities Change
0.00M-0.01M0.00M0.00M0.00M0.00M-0.01M0.02M
Other Working Capital ChangesOther WC Changes
0.02M0.01M0.02M-0.53M0.01M0.09M0.16M-0.10M0.06M-0.03M0.08M-0.19M0.02M0.01M0.02M-0.06M-0.06M0.06M0.01M0.05M
Cash from OperationsCash from Ops.
-0.65M-0.63M-0.38M-1.76M-1.30M-1.53M-1.36M-1.53M-1.62M-2.35M-1.53M-1.71M-1.68M-1.64M-2.65M-2.48M-2.56M-3.23M-3.20M-3.87M
Investing Activities
Capital ExpendituresCapex
0.03M0.00M169.00-0.01M0.04M0.03M0.01M1.000.05M0.01M0.00M1.000.01M0.09M0.08M
Change in Property, Plant and EquipmentChange in PP&E
-0.03M0.00M-169.000.01M-0.04M-0.03M-0.01M-1.00-0.05M-0.01M0.00M-1.00-0.01M-0.09M-0.08M
Cash from Investing ActivitiesCash from Investing
-0.03M0.00M-2.19M0.01M-0.04M-0.03M-0.01M-1.00-0.05M-0.01M0.00M-1.00-0.01M-0.09M-0.08M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.95M0.48M0.80M-0.56M-0.08M-0.13M-251,745.79M-0.04M-0.07M0.10M-0.04M-0.05M0.12M
Long-Term Debt RepaymentsLT Debt Repayment
0.03M0.02M0.08M0.09M0.09M0.09M0.09M0.10M0.09M0.06M0.06M0.08M0.02M0.02M
Net Long-Term Debt Issued (Repaid)Net LT Debt
1.95M0.48M0.77M-0.58M-0.08M-0.13M-251,745.79M-0.08M-0.09M-0.09M-0.09M-0.09M-0.14M-0.17M0.04M-0.06M-0.12M-0.07M0.10M
Short-Term Debt issuancesST Debt Issuance
555,147.93M0.03M-851.000.26M-0.10M
Short-Term Debt repaymentsST Debt Repayment
0.08M0.13M0.04M0.04M0.07M-0.10M0.04M0.05M
Net Short-Term Debt Issued (Repaid)Net ST Debt
555,147.93M-0.08M-0.13M-0.04M0.03M-851.000.26M-0.10M-0.04M-0.07M0.10M-0.04M-0.05M
Net Debt Issuances and RepaymentsNet Debt Issuance
1.95M0.48M555,148.71M-0.58M-0.17M-0.25M-251,745.83M-0.08M-0.06M-0.09M0.17M-0.19M-0.18M-0.24M0.14M-0.06M-0.16M-0.11M0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M4.51M
Net Shares Issued and RepurchasedNet Shares Issued
2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M4.51M
Net Equity Issued and RepurchasedNet Equity Issued
2.08M147.002.29M2.69M1.17M3.19M9.73M1.80M4.51M
Other financing activities (as filed)
-0.17M-0.40M0.52M-0.48M1.07M
Cash from Financing ActivitiesCash from Financing
1.77M0.30M-0.44M15.04M-0.56M-0.08M-0.13M-0.05M-0.08M2.02M-0.09M1.67M2.03M1.03M3.02M9.34M1.34M-0.12M2.62M4.07M
Additional items
Change in Cash
1.12M-0.33M-0.81M13.28M-2.08M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M0.12M
Ending Cash Balance
1.36M1.03M0.21M13.50M11.41M9.77M8.28M4.51M2.82M2.45M0.80M0.76M1.11M0.44M0.80M7.67M6.45M3.10M2.43M2.55M
Free Cash FlowFCF
-0.65M-0.63M-0.38M-1.76M-1.30M-1.56M-1.36M-1.53M-1.60M-2.39M-1.56M-1.72M-1.68M-1.69M-2.66M-2.48M-2.56M-3.23M-3.29M-3.95M
Net Cash FlowNCF
1.12M-0.33M-0.81M13.28M-1.86M-1.64M-1.49M-3.77M-1.69M-0.37M-1.65M-0.04M0.35M-0.66M0.36M6.87M-1.22M-3.35M-0.67M0.12M
Interest Paid
0.01M-0.01M0.01M0.03M0.02M0.02M-0.03M0.00M542.000.00M0.00M0.04M0.01M0.00M0.02M
Income Taxes PaidTaxes Paid
0.00M0.00M0.03M0.00M0.01M0.00M0.00M0.00M0.01M0.00M0.01M0.01M0.03M0.00M-0.02M

bioAffinity Technologies Cash Flow Statement API

Pull bioAffinity Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIAF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY